Drug Trial Radar · NCT05674929
An Open-Label, Single Dose Study in Patients With Alcohol Use Disorder
Last checked: Nov 19, 2026Latest source record: May 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
13
Actual
Start
May 30, 2023
Primary completion
Oct 2, 2024
Study completion Oct 2, 2024
Sponsor
- Lead sponsor
- Beckley Psytech LimitedIndustry
- Sponsor type
- Industry
- First posted
- Jan 9, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 64 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
An open-label, Phase 2a study to evaluate the safety, tolerability, and pharmacodynamic effects of a single intranasal dose of BPL-003 combined with relapse prevention psychological support, to explore the potential effects on alcohol use and related symptoms in patients with Alcohol Use Disorder.
Conditions
- Alcohol Use Disorder
Interventions
BPL-003Drug
A single dose administered intranasally
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Treatment Emergent Adverse EventsTime frame: Up to 12 weeks
- Percentage of Participants With Clinically Significant Abnormal Laboratory TestsTime frame: Up to 12 weeks
- Percentage of Participants With Clinically Significant Abnormal Vital SignsTime frame: Up to 12 weeks
- Number of Participants With Post-baseline Suicidal Ideation or Behaviour Based on C-SSRS ScoreTime frame: Up to 12 weeks
- Time to Readiness for Discharge Post-dose Using the Readiness for Discharge Questionnaire (RDQ)Time frame: 1 Day
- Percentage of Participants With Occurrence of Reactivation Using the Reactivation Questionnaire (ReAQ)Time frame: Up to 12 weeks
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Clerkenwell Health
London, United Kingdom
King's College London
London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.